Centre Hospitalier Intercommunal de Compiègne-Noyon
12
3
5
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
8.3%
1 terminated/withdrawn out of 12 trials
80.0%
-6.6% vs industry average
8%
1 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment reporting
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Amikacin Liposome Inhalation Suspension for Treatment of Mycobacterium Xenopi Pulmonary Infection
Role: collaborator
Risk Factors for Poor Tolerance of Ureteral Double-J Stent
Role: collaborator
The Multitasking Rehabilitation She Enhanced Walking Speed Compared to the Simple Post Stroke Rehabilitation Task (AVC)?
Role: collaborator
Screening for Postpartum Depression and Associated Risk Factors Among Women Who Deliver in Four Hospital in France During the COVID-19 Epidemic
Role: collaborator
Research of Predictive Factors to Immune Thrombopenic Purpura
Role: collaborator
Treatment of COVID-19 by Nebulization of Inteferon Beta 1b Efficiency and Safety Study
Role: collaborator
Non-inferiority of Nurse-performed Versus Interventional Cardiologist-Performed Radial Catheterization in Elective Coronary Angiography: a Single-center, Open-label Randomized Trial.
Role: lead
Comparison of Landiolol Versus Standard of Care for Prevention of Mortality in Patients Hospitalized for a Septic Shock With Hypercontractility
Role: collaborator
Endoscopic Management of Fistulas Related to Sleeve Gastrectomy With Double Pigtail Stents According to the BARTOLI Technique
Role: collaborator
Blue Protocol Assessment
Role: collaborator
S-ICD French Cohort Study (HONEST)
Role: collaborator
Tendon Adaptations to Training - Effect of Ageing
Role: collaborator
All 12 trials loaded